BAVDEGALUTAMIDE |
BAVDEGALUTAMIDE : Degrader (PROTAC) of AR
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| AR (Mutant:WT, F877L, T878A, M896V, and H875Y) |
|
Degrader (PROTAC)
up to 30 nM
Selectivity
In Cell Selectivity Assessment
Selectivity Assessment Description:
In the MCF-7 breast cancer cell line, bavdegalutamide treatment (30–300 nmol/L) resulted in the degr ...
In Cell Selectivity Assessment
Potency Assay Off-Target:
Unbiased proteomic screen of nearly 4,000 detectable proteins in VCaP cells showed that treatment wi ...
In Cell Selectivity Assessment
Selectivity Assessment Description:
Treatment of Ramos cells with increasing concentrations of bavdegalutamide did not lead to degradati ...
Potency Cellular
In Vitro
AR
(Mutant:WT, F877L, T878A, M896V, and H875Y)
Mode of Action: Degrader (PROTAC)
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1158/1535-7163.MCT-23-0655
In Vivo Validations
Mouse
Dose: 2 mg/Kg
Route of delivery:
Intravenous
Plasma half life:
11.4 ± 0.51 h
Systemic clearance:
180.9 ± 30.8 mL/h/Kg
Cmax:
1263 ± 99 ng/mL
Tmax:
0.05 h
Area Under the Curve::
11304 ± 1964 ng*h/mL
Volume of Distribution at Steady-State:
2636 ± 402 mL/Kg
DOI Reference: 10.3390/molecules27061977
Dose: 5 mg/Kg
Route of delivery:
Oral
Plasma half life:
14.57 ± 2.479 h
Cmax:
612.0 ± 88.38 ng/mL
Tmax:
4.800 ± 1.789 h
Area Under the Curve::
10,707 ± 1176 ng∙h/mL
Bioavailability:
37.89 ± 4.16 %
DOI Reference: 10.3390/molecules27061977
Rat
Dose: 2 mg/Kg
Route of delivery:
Intravenous
Plasma half life:
13.62 ± 1.43 h
Systemic clearance:
413.6 ± 31.7 mL/h/Kg
Cmax:
2525 ± 292 ng/mL
Tmax:
0.083 ± 0.000 h
Area Under the Curve::
4857 ± 381 ng∙h/mL
Volume of Distribution at Steady-State:
5775 ± 320 mL/Kg
DOI Reference: 10.3390/molecules27061977
Dose: 5 mg/Kg
Route of delivery:
Oral
Plasma half life:
17.67 ± 3.21 h
Cmax:
110.5 ± 9.2 ng/mL
Tmax:
5.500 ± 1.915 h
Area Under the Curve::
2894 ± 318 ng∙h/mL
Bioavailability:
23.83 ± 2.62 %
DOI Reference: 10.3390/molecules27061977
Chemical Information
| Molecular Formula | C41H43ClFN9O6 |
| SMILEs | N#Cc1ccc(O[C@H]2CC[C@H](NC(=O)c3ccc(N4CCC(CN5CCN(c6cc7c(cc6F)C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)CC4)nn3)CC2)cc1Cl |
| InChI | InChI=1S/C41H43ClFN9O6/c42-31-19-28(4-1-25(31)22-44)58-27-5-2-26(3-6-27)45-38(54)33-7-9-36(48-47-33)51-13-11-24(12-14-51)23-49-15-17-50(18-16-49)35-21-30-29(20-32(35)43)40(56)52(41(30)57)34-8-10-37(53)46-39(34)55/h1,4,7,9,19-21,24,26-27,34H,2-3,5-6,8,10-18,23H2,(H,45,54)(H,46,53,55)/t26-,27-,34? |
| Molecular weight | 811.30 Da |
| AlogP | 3.700580000000002 |
| HBond acceptors | 15 |
| HBond donors | 2 |
| Atoms | 101 |